Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
LKB1/STRAD promotes axon initiation during neuronal polarization.
A double-blind clinical trial of mitoxantrone versus methylprednisolone in relapsing, secondary progressive multiple sclerosis.
Incidence of infusion-associated reactions with rituximab for treating multiple sclerosis: a retrospective analysis of patients treated at a US centre.
Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial.
Prediction of oxygen uptake during walking in ambulatory persons with multiple sclerosis.
Ampyra (dalfampridine)
Extension CombiRx data show no benefit of combined MS drugs
Use of interleukin-2 for management of natalizumab-associated progressive multifocal leukoencephalopathy: case report and review of literature.
Multiple sclerosis: clinical presentation, diagnosis and treatment.
Getting a Handle on Lymphopenia With Tecfidera
Testing the measurement invariance of the University of Washington Self-Efficacy Scale short form across four diagnostic subgroups.
Treatments for relapsing-remitting multiple sclerosis: summarising current information by network meta-analysis.
An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica.
Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial.
Mitoxantrone: benefits and risks in multiple sclerosis patients.
Channelopathy-related SCN10A gene variants predict cerebellar dysfunction in multiple sclerosis.
Lithium Controls Central Nervous System Autoimmunity through Modulation of IFN-γ Signaling.
Individual oligodendrocytes have only a few hours in which to generate new myelin sheaths in vivo.
Mitoxantrone-related acute leukemia in MS: An open or closed book?
Dimethyl fumarate (BG-12, Tecfidera) - NICE says yes in draft final guidance
Cognitive Impairment in Multiple Sclerosis: Clinical Manifestation, Neuroimaging Correlates, and Treatment.
A comparison of phase imaging and quantitative susceptibility mapping in the imaging of multiple sclerosis lesions at ultrahigh field.
45th European Brain and Behaviour Society Meeting
Epigenetic Modulation of Human Induced Pluripotent Stem Cell Differentiation to Oligodendrocytes.
The effects of teriflunomide on lymphocyte subpopulations in human peripheral blood mononuclear cells in vitro.
Pages
« first
‹ previous
…
93
94
95
96
97
98
99
100
101
…
next ›
last »